The Technology Behind Bluebird Bio

The Technology Behind Bluebird Bio

Assessment

Interactive Video

Business, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses Bluebird Bio's role in the biotech industry, focusing on gene therapy, cancer immunotherapy, and gene editing. It highlights the importance of Boston's ecosystem, including academia, innovation, and investors. The CEO, Nick Lashley, emphasizes the need for a global talent pool and the impact of immigration policies. The discussion also covers venture capital, public markets, and Bluebird's long-term vision, including deals with Novartis and GSK to advance gene therapy technologies.

Read more

7 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What are the main areas of focus for Bluebird Bio?

Pharmaceutical manufacturing

Gene therapy, cancer immunotherapy, and gene editing

Medical devices and diagnostics

Nutritional supplements

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a key differentiator for Bluebird Bio's gene therapy programs?

Focus on cosmetic applications

Potential to cure diseases

Incremental benefits for patients

Low-cost treatments

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How does the biotech ecosystem in Boston support companies like Bluebird Bio?

By providing a large local market

Through a combination of academia, medical institutions, and investors

By offering tax incentives

Through government grants

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is a global talent pool important for Bluebird Bio?

To increase brand recognition

To comply with international regulations

To ensure a diverse range of ideas and expertise

To reduce labor costs

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What role do venture capital firms play in the biotech ecosystem?

They provide legal advice

They help seed and start companies

They offer marketing services

They manage clinical trials

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What challenge does Bluebird Bio face as a public company?

Dealing with frequent product recalls

Balancing short-term and long-term goals

Competing with tech companies

Managing a large number of employees

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How does Bluebird Bio view its licensing deals with companies like Novartis?

As a way to block competitors

As an opportunity to share intellectual property

As a strategy to reduce research costs

As a method to increase product prices